There is some debate as to whether the SNP is associated with prostate cancer or simply correlates with PSA expression levels, as controls used for stage 1 of this GWAS were limited to those with low PSA levels (<0.5 ng/ml) [19], [23]. This evidence concerns the gene KLK3 and prostate cancer.